Global Nucleic-Acid Based Gene Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Nucleic-Acid Based Gene Therapeutics market size will reach US$ million by 2031.
Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nucleic-Acid Based Gene Therapeutics Industry Forecast” looks at past sales and reviews total world Nucleic-Acid Based Gene Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic-Acid Based Gene Therapeutics sales for 2025 through 2031. With Nucleic-Acid Based Gene Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic-Acid Based Gene Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Nucleic-Acid Based Gene Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic-Acid Based Gene Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic-Acid Based Gene Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic-Acid Based Gene Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic-Acid Based Gene Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic-Acid Based Gene Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nucleic-Acid Based Gene Therapeutics Industry Forecast” looks at past sales and reviews total world Nucleic-Acid Based Gene Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic-Acid Based Gene Therapeutics sales for 2025 through 2031. With Nucleic-Acid Based Gene Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic-Acid Based Gene Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Nucleic-Acid Based Gene Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic-Acid Based Gene Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic-Acid Based Gene Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic-Acid Based Gene Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic-Acid Based Gene Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic-Acid Based Gene Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- DNA
- RNA
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Wave Life Sciences
- Phylogica
- Benitec Biopharma
- Celsion
- Copernicus Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic-Acid Based Gene Therapeutics Market Size (2020-2031)
2.1.2 Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic-Acid Based Gene Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Nucleic-Acid Based Gene Therapeutics Segment by Type
2.2.1 DNA
2.2.2 RNA
2.3 Nucleic-Acid Based Gene Therapeutics Market Size by Type
2.3.1 Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Nucleic-Acid Based Gene Therapeutics Segment by Application
2.4.1 Academic and Government Research Institutes
2.4.2 Pharmaceutical and Biotechnology Companies
2.4.3 Contract Research Organizations
2.4.4 Hospitals and Diagnostic Centers
2.4.5 Others
2.5 Nucleic-Acid Based Gene Therapeutics Market Size by Application
2.5.1 Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
3 NUCLEIC-ACID BASED GENE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Player
3.1.1 Global Nucleic-Acid Based Gene Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic-Acid Based Gene Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC-ACID BASED GENE THERAPEUTICS BY REGION
4.1 Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025)
4.2 Global Nucleic-Acid Based Gene Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
4.4 APAC Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
4.5 Europe Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025)
5.2 Americas Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
5.3 Americas Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025)
6.2 APAC Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
6.3 APAC Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025)
7.2 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
7.3 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic-Acid Based Gene Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC-ACID BASED GENE THERAPEUTICS MARKET FORECAST
10.1 Global Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Nucleic-Acid Based Gene Therapeutics Forecast
10.1.3 APAC Nucleic-Acid Based Gene Therapeutics Forecast
10.1.4 Europe Nucleic-Acid Based Gene Therapeutics Forecast
10.1.5 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Forecast
10.2 Americas Nucleic-Acid Based Gene Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic-Acid Based Gene Therapeutics Forecast
10.2.2 Canada Market Nucleic-Acid Based Gene Therapeutics Forecast
10.2.3 Mexico Market Nucleic-Acid Based Gene Therapeutics Forecast
10.2.4 Brazil Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3 APAC Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.3.1 China Nucleic-Acid Based Gene Therapeutics Market Forecast
10.3.2 Japan Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.3 Korea Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.4 Southeast Asia Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.5 India Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.6 Australia Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4 Europe Nucleic-Acid Based Gene Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.2 France Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.3 UK Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.4 Italy Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.5 Russia Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5.2 South Africa Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5.3 Israel Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5.4 Turkey Market Nucleic-Acid Based Gene Therapeutics Forecast
10.6 Global Nucleic-Acid Based Gene Therapeutics Forecast by Type (2026-2031)
10.7 Global Nucleic-Acid Based Gene Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic-Acid Based Gene Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Information
11.1.2 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product Offered
11.1.3 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Wave Life Sciences Main Business Overview
11.1.5 Wave Life Sciences Latest Developments
11.2 Phylogica
11.2.1 Phylogica Company Information
11.2.2 Phylogica Nucleic-Acid Based Gene Therapeutics Product Offered
11.2.3 Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Phylogica Main Business Overview
11.2.5 Phylogica Latest Developments
11.3 Benitec Biopharma
11.3.1 Benitec Biopharma Company Information
11.3.2 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product Offered
11.3.3 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Benitec Biopharma Main Business Overview
11.3.5 Benitec Biopharma Latest Developments
11.4 Celsion
11.4.1 Celsion Company Information
11.4.2 Celsion Nucleic-Acid Based Gene Therapeutics Product Offered
11.4.3 Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Celsion Main Business Overview
11.4.5 Celsion Latest Developments
11.5 Copernicus Therapeutics
11.5.1 Copernicus Therapeutics Company Information
11.5.2 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product Offered
11.5.3 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Copernicus Therapeutics Main Business Overview
11.5.5 Copernicus Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic-Acid Based Gene Therapeutics Market Size (2020-2031)
2.1.2 Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic-Acid Based Gene Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Nucleic-Acid Based Gene Therapeutics Segment by Type
2.2.1 DNA
2.2.2 RNA
2.3 Nucleic-Acid Based Gene Therapeutics Market Size by Type
2.3.1 Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Nucleic-Acid Based Gene Therapeutics Segment by Application
2.4.1 Academic and Government Research Institutes
2.4.2 Pharmaceutical and Biotechnology Companies
2.4.3 Contract Research Organizations
2.4.4 Hospitals and Diagnostic Centers
2.4.5 Others
2.5 Nucleic-Acid Based Gene Therapeutics Market Size by Application
2.5.1 Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
3 NUCLEIC-ACID BASED GENE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Player
3.1.1 Global Nucleic-Acid Based Gene Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic-Acid Based Gene Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC-ACID BASED GENE THERAPEUTICS BY REGION
4.1 Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025)
4.2 Global Nucleic-Acid Based Gene Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
4.4 APAC Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
4.5 Europe Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025)
5.2 Americas Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
5.3 Americas Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025)
6.2 APAC Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
6.3 APAC Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025)
7.2 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
7.3 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic-Acid Based Gene Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC-ACID BASED GENE THERAPEUTICS MARKET FORECAST
10.1 Global Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Nucleic-Acid Based Gene Therapeutics Forecast
10.1.3 APAC Nucleic-Acid Based Gene Therapeutics Forecast
10.1.4 Europe Nucleic-Acid Based Gene Therapeutics Forecast
10.1.5 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Forecast
10.2 Americas Nucleic-Acid Based Gene Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic-Acid Based Gene Therapeutics Forecast
10.2.2 Canada Market Nucleic-Acid Based Gene Therapeutics Forecast
10.2.3 Mexico Market Nucleic-Acid Based Gene Therapeutics Forecast
10.2.4 Brazil Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3 APAC Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.3.1 China Nucleic-Acid Based Gene Therapeutics Market Forecast
10.3.2 Japan Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.3 Korea Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.4 Southeast Asia Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.5 India Market Nucleic-Acid Based Gene Therapeutics Forecast
10.3.6 Australia Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4 Europe Nucleic-Acid Based Gene Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.2 France Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.3 UK Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.4 Italy Market Nucleic-Acid Based Gene Therapeutics Forecast
10.4.5 Russia Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5.2 South Africa Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5.3 Israel Market Nucleic-Acid Based Gene Therapeutics Forecast
10.5.4 Turkey Market Nucleic-Acid Based Gene Therapeutics Forecast
10.6 Global Nucleic-Acid Based Gene Therapeutics Forecast by Type (2026-2031)
10.7 Global Nucleic-Acid Based Gene Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic-Acid Based Gene Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Information
11.1.2 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product Offered
11.1.3 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Wave Life Sciences Main Business Overview
11.1.5 Wave Life Sciences Latest Developments
11.2 Phylogica
11.2.1 Phylogica Company Information
11.2.2 Phylogica Nucleic-Acid Based Gene Therapeutics Product Offered
11.2.3 Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Phylogica Main Business Overview
11.2.5 Phylogica Latest Developments
11.3 Benitec Biopharma
11.3.1 Benitec Biopharma Company Information
11.3.2 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product Offered
11.3.3 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Benitec Biopharma Main Business Overview
11.3.5 Benitec Biopharma Latest Developments
11.4 Celsion
11.4.1 Celsion Company Information
11.4.2 Celsion Nucleic-Acid Based Gene Therapeutics Product Offered
11.4.3 Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Celsion Main Business Overview
11.4.5 Celsion Latest Developments
11.5 Copernicus Therapeutics
11.5.1 Copernicus Therapeutics Company Information
11.5.2 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product Offered
11.5.3 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Copernicus Therapeutics Main Business Overview
11.5.5 Copernicus Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic-Acid Based Gene Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA
Table 4. Major Players of RNA
Table 5. Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Nucleic-Acid Based Gene Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Nucleic-Acid Based Gene Therapeutics Key Players Head office and Products Offered
Table 14. Nucleic-Acid Based Gene Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Nucleic-Acid Based Gene Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Nucleic-Acid Based Gene Therapeutics
Table 39. Key Market Challenges & Risks of Nucleic-Acid Based Gene Therapeutics
Table 40. Key Industry Trends of Nucleic-Acid Based Gene Therapeutics
Table 41. Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Wave Life Sciences Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 46. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product Offered
Table 47. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Wave Life Sciences Main Business
Table 49. Wave Life Sciences Latest Developments
Table 50. Phylogica Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 51. Phylogica Nucleic-Acid Based Gene Therapeutics Product Offered
Table 52. Phylogica Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Phylogica Main Business
Table 54. Phylogica Latest Developments
Table 55. Benitec Biopharma Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 56. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product Offered
Table 57. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Benitec Biopharma Main Business
Table 59. Benitec Biopharma Latest Developments
Table 60. Celsion Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 61. Celsion Nucleic-Acid Based Gene Therapeutics Product Offered
Table 62. Celsion Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Celsion Main Business
Table 64. Celsion Latest Developments
Table 65. Copernicus Therapeutics Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 66. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product Offered
Table 67. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Copernicus Therapeutics Main Business
Table 69. Copernicus Therapeutics Latest Developments
Table 1. Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic-Acid Based Gene Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA
Table 4. Major Players of RNA
Table 5. Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Nucleic-Acid Based Gene Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Nucleic-Acid Based Gene Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Nucleic-Acid Based Gene Therapeutics Key Players Head office and Products Offered
Table 14. Nucleic-Acid Based Gene Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Nucleic-Acid Based Gene Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Nucleic-Acid Based Gene Therapeutics
Table 39. Key Market Challenges & Risks of Nucleic-Acid Based Gene Therapeutics
Table 40. Key Industry Trends of Nucleic-Acid Based Gene Therapeutics
Table 41. Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Wave Life Sciences Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 46. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product Offered
Table 47. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Wave Life Sciences Main Business
Table 49. Wave Life Sciences Latest Developments
Table 50. Phylogica Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 51. Phylogica Nucleic-Acid Based Gene Therapeutics Product Offered
Table 52. Phylogica Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Phylogica Main Business
Table 54. Phylogica Latest Developments
Table 55. Benitec Biopharma Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 56. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product Offered
Table 57. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Benitec Biopharma Main Business
Table 59. Benitec Biopharma Latest Developments
Table 60. Celsion Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 61. Celsion Nucleic-Acid Based Gene Therapeutics Product Offered
Table 62. Celsion Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Celsion Main Business
Table 64. Celsion Latest Developments
Table 65. Copernicus Therapeutics Details, Company Type, Nucleic-Acid Based Gene Therapeutics Area Served and Its Competitors
Table 66. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product Offered
Table 67. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Copernicus Therapeutics Main Business
Table 69. Copernicus Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Nucleic-Acid Based Gene Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic-Acid Based Gene Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic-Acid Based Gene Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Nucleic-Acid Based Gene Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type in 2024
Figure 10. Nucleic-Acid Based Gene Therapeutics in Academic and Government Research Institutes
Figure 11. Global Nucleic-Acid Based Gene Therapeutics Market: Academic and Government Research Institutes (2020-2025) & ($ millions)
Figure 12. Nucleic-Acid Based Gene Therapeutics in Pharmaceutical and Biotechnology Companies
Figure 13. Global Nucleic-Acid Based Gene Therapeutics Market: Pharmaceutical and Biotechnology Companies (2020-2025) & ($ millions)
Figure 14. Nucleic-Acid Based Gene Therapeutics in Contract Research Organizations
Figure 15. Global Nucleic-Acid Based Gene Therapeutics Market: Contract Research Organizations (2020-2025) & ($ millions)
Figure 16. Nucleic-Acid Based Gene Therapeutics in Hospitals and Diagnostic Centers
Figure 17. Global Nucleic-Acid Based Gene Therapeutics Market: Hospitals and Diagnostic Centers (2020-2025) & ($ millions)
Figure 18. Nucleic-Acid Based Gene Therapeutics in Others
Figure 19. Global Nucleic-Acid Based Gene Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 20. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application in 2024
Figure 21. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Player in 2024
Figure 22. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas Nucleic-Acid Based Gene Therapeutics Value Market Share by Country in 2024
Figure 28. United States Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region in 2024
Figure 33. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Figure 34. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Country in 2024
Figure 42. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Figure 43. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. France Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. China Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. India Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. France Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 79. Turkey Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Nucleic-Acid Based Gene Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic-Acid Based Gene Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic-Acid Based Gene Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic-Acid Based Gene Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Nucleic-Acid Based Gene Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type in 2024
Figure 10. Nucleic-Acid Based Gene Therapeutics in Academic and Government Research Institutes
Figure 11. Global Nucleic-Acid Based Gene Therapeutics Market: Academic and Government Research Institutes (2020-2025) & ($ millions)
Figure 12. Nucleic-Acid Based Gene Therapeutics in Pharmaceutical and Biotechnology Companies
Figure 13. Global Nucleic-Acid Based Gene Therapeutics Market: Pharmaceutical and Biotechnology Companies (2020-2025) & ($ millions)
Figure 14. Nucleic-Acid Based Gene Therapeutics in Contract Research Organizations
Figure 15. Global Nucleic-Acid Based Gene Therapeutics Market: Contract Research Organizations (2020-2025) & ($ millions)
Figure 16. Nucleic-Acid Based Gene Therapeutics in Hospitals and Diagnostic Centers
Figure 17. Global Nucleic-Acid Based Gene Therapeutics Market: Hospitals and Diagnostic Centers (2020-2025) & ($ millions)
Figure 18. Nucleic-Acid Based Gene Therapeutics in Others
Figure 19. Global Nucleic-Acid Based Gene Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 20. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application in 2024
Figure 21. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Player in 2024
Figure 22. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas Nucleic-Acid Based Gene Therapeutics Value Market Share by Country in 2024
Figure 28. United States Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region in 2024
Figure 33. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Figure 34. APAC Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Country in 2024
Figure 42. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Figure 43. Europe Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. France Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Nucleic-Acid Based Gene Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. China Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. India Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. France Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 79. Turkey Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Nucleic-Acid Based Gene Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Nucleic-Acid Based Gene Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2025-2031
US$ 3,660.00
March 2025
105 pages